Please login to the form below

Not currently logged in
Email:
Password:

Neopharm

This page shows the latest Neopharm news and features for those working in and with pharma, biotech and healthcare.

Fresenius Kabi buys Akorn and Merck's biosimilar businesses

Fresenius Kabi buys Akorn and Merck's biosimilar businesses

The Merck agreement comes four years after Fresenius hived off its biotech business to the owners of Israeli group Neopharm, saying it wanted to narrow down its focus to intravenous drugs,

Latest news

  • Fresenius sells biotech business Fresenius sells biotech business

    German healthcare group Fresenius has sold its biotech business for an undisclosed amount to the owners of Neopharm, Israel's second-largest pharma company. ... David Fuhrer, chairman and CEO of Neopharm, said: "The acquisition represents a cornerstone

  • Novartis gains licence for GW's Sativex

    Sativex is licensed to Otsuka Pharmaceutical in the US, to Almirall in Europe (excluding the UK), to Bayer HealthCare in the UK and Canada, and to Neopharm Group in Israel/Palestine.

  • Going for gold

    Additionally, NeoPharm's liposomal candidate, LEP-ETU, is expected to enter phase II clinical trials for breast cancer in 2008.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Webinar: Usability and UX: You’ve been asked to test...What next?
Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST...
Event: EphMRA Annual Conference
We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland....
Research Partnership and Janssen awarded runner-up in MR Excellence Awards
...

Infographics